Tissue-specific microvascular endothelial cells show distinct capacity to activate NK cells: Implications for the pathophysiology of granulomatosis with polyangiitis

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3399-3408

  Tognarelli, Sara ^g   Gayet, Julie ^a,b   Lambert, Marion ^a,b   Dupuy, Stéphanie ^a   Karras, Alexandre ^b,c   Cohen, Pascal ^b,d   Guillevin, Loïc ^b,d   De Menthon, Mathilde ^a,e   Caillat Zucman, Sophie ^a,b,f  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Institut Cochin   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; FRACTALKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOBLASTIN; NATURAL KILLER CELL RECEPTOR NKG2D; NECTIN 2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DEGRANULATION; FEMALE; GRANULOMATOSIS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KIDNEY PARENCHYMA; LUNG PARENCHYMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MALE; MICROSCOPIC POLYANGIITIS; MICROVASCULAR ENDOTHELIAL CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; UPREGULATION;

ADULT; AGED; CELL LINE; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DERMIS; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE ACTIVATION; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; ORGAN SPECIFICITY; VASCULAR CELL ADHESION MOLECULE-1; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 84897498698     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301508     Document Type: Article

References (50)

1. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70: 427-451.
2. Kallenberg, C. G. 2011. Pathogenesis of ANCA-associated vasculitides. Ann. Rheum. Dis. 70(Suppl. 1): i59-i63.
3. Wilde, B., P. van Paassen, O. Witzke, and J. W. Tervaert. 2011. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 79: 599-612.
4. Bosch, X., A. Guilabert, and J. Font. 2006. Antineutrophil cytoplasmic antibodies. Lancet 368: 404-418.
5. Jennette, J. C., H. Xiao, and R. J. Falk. 2006. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J. Am. Soc. Nephrol. 17: 1235-1242.
6. Abdulahad, W. H., P. Lamprecht, and C. G. Kallenberg. 2011. T-helper cells as new players in ANCA-associated vasculitides. Arthritis Res. Ther. 13: 236.
7. Capraru, D., A. Müller, E. Csernok, W. L. Gross, K. Holl-Ulrich, J. Northfield, P. Klenerman, K. Herlyn, J. Holle, S. Gottschlich, et al. 2008. Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin. Immunol. 127: 144-150.
8. de Menthon, M., M. Lambert, E. Guiard, S. Tognarelli, B. Bienvenu, A. Karras, L. Guillevin, and S. Caillat-Zucman. 2011. Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's). Arthritis Rheum. 63: 2116-2126.
9. Melder, R. J., G. C. Koenig, B. P. Witwer, N. Safabakhsh, L. L. Munn, and R. K. Jain. 1996. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med. 2: 992-997.
10. Bielawska-Pohl, A., C. Crola, A. Caignard, C. Gaudin, D. Dus, C. Kieda, and S. Chouaib. 2005. Human NK cells lyse organ-specific endothelial cells: analysis of adhesion and cytotoxic mechanisms. J. Immunol. 174: 5573-5582.
11. Cines, D. B., E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91: 3527-3561.
12. Aird, W. C. 2007. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100: 174-190.
13. Aird, W. C. 2007. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100: 158-173.
14. Regan, E. R., and W. C. Aird. 2012. Dynamical systems approach to endothelial heterogeneity. Circ. Res. 111: 110-130.
15. Hüe, S., R. C. Monteiro, S. Berrih-Aknin, and S. Caillat-Zucman. 2003. Potential role of NKG2D/MHC class I-related chain A interaction in intrathymic maturation of single-positive CD8 T cells. J. Immunol. 171: 1909-1917.
16. Ades, E. W., F. J. Candal, R. A. Swerlick, V. G. George, S. Summers, D. C. Bosse, and T. J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99: 683-690.
17. Videm, V., and M. Albrigtsen. 2008. Soluble ICAM-1 and VCAM-1 as markers of endothelial activation. Scand. J. Immunol. 67: 523-531.
18. Perrot-Applanat, M., S. Vacher, A. Toullec, I. Pelaez, G. Velasco, F. Cormier, S. Saad Hel, R. Lidereau, V. Baud, and I. Bièche. 2011. Similar NF-kB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. PLoS ONE 6: e21589.
19. Maurus, C. F., M. K. Schneider, D. Schmidt, G. Zünd, and J. D. Seebach. 2006. Activation of human microvascular endothelial cells with TNF-alpha and hypoxia/reoxygenation enhances NK-cell adhesion, but not NK-cytotoxicity. Transplantation 81: 1204-1211.
20. Zanone, M. M., E. Favaro, P. G. Conaldi, J. Greening, A. Bottelli, P. C. Perin, N. J. Klein, M. Peakman, and G. Camussi. 2003. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J. Immunol. 171: 438-446.
21. Favaro, E., A. Bottelli, B. Lozanoska-Ochser, E. Ferioli, G. C. Huang, N. Klein, A. Chiaravalli, P. C. Perin, G. Camussi, M. Peakman, et al. 2005. Primary and immortalised human pancreatic islet endothelial cells: phenotypic and immunological characterisation. Diabetologia 48: 2552-2562.
22. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membranebound chemokine with a CX3C motif. Nature 385: 640-644.
23. Yoneda, O., T. Imai, S. Goda, H. Inoue, A. Yamauchi, T. Okazaki, H. Imai, O. Yoshie, E. T. Bloom, N. Domae, and H. Umehara. 2000. Fractalkine-mediated endothelial cell injury by NK cells. J. Immunol. 164: 4055-4062.
24. Scaldaferri, F., M. Sans, S. Vetrano, C. Correale, V. Arena, N. Pagano, G. Rando, F. Romeo, A. E. Potenza, A. Repici, et al. 2009. The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur. J. Immunol. 39: 290-300.
25. Beck, G. C., B. A. Yard, A. J. Breedijk, K. Van Ackern, and F. J. Van DerWoude. 1999. Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin. Exp. Immunol. 118: 298-303.
26. Taflin, C., B. Favier, J. Baudhuin, A. Savenay, P. Hemon, A. Bensussan, D. Charron, D. Glotz, and N. Mooney. 2011. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc. Natl. Acad. Sci. USA 108: 2891-2896.
27. Sans, M., S. Danese, C. de la Motte, H. S. de Souza, B. M. Rivera-Reyes, G. A. West, M. Phillips, J. A. Katz, and C. Fiocchi. 2007. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. Gastroenterology 132: 139-153.
28. Pigott, R., L. P. Dillon, I. H. Hemingway, and A. J. Gearing. 1992. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187: 584-589.
29. Kitani, A., N. Nakashima, T. Matsuda, B. Xu, S. Yu, T. Nakamura, and T. Matsuyama. 1996. T cells bound by vascular cell adhesion molecule-1/CD106 in synovial fluid in rheumatoid arthritis: inhibitory role of soluble vascular cell adhesion molecule-1 in T cell activation. J. Immunol. 156: 2300-2308.
30. Altomonte, M., A. Gloghini, G. Bertola, A. Gasparollo, A. Carbone, S. Ferrone, and M. Maio. 1993. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 53: 3343-3348.
31. Sánchez-Rovira, P., E. Jimenez, J. Carracedo, I. C. Barneto, R. Ramirez, and E. Aranda. 1998. Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur. J. Cancer 34: 394-398.
32. Rose, D. M., P. M. Cardarelli, R. R. Cobb, and M. H. Ginsberg. 2000. Soluble VCAM-1 binding to alpha4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood 95: 602-609.
33. Fiore, E., C. Fusco, P. Romero, and I. Stamenkovic. 2002. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21: 5213-5223.
34. Berger, S. P., M. A. Seelen, P. S. Hiemstra, J. S. Gerritsma, E. Heemskerk, F. J. van der Woude, and M. R. Daha. 1996. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J. Am. Soc. Nephrol. 7: 694-701.
35. Molino, M., M. J. Woolkalis, J. Reavey-Cantwell, D. Praticó, P. Andrade-Gordon, E. S. Barnathan, and L. F. Brass. 1997. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J. Biol. Chem. 272: 11133-11141.
36. Taekema-Roelvink, M. E., C. Kooten, S. V. Kooij, E. Heemskerk, and M. R. Daha. 2001. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J. Am. Soc. Nephrol. 12: 932-940.
37. Seitz, I., S. Hess, H. Schulz, R. Eckl, G. Busch, H. P. Montens, R. Brandl, S. Seidl, A. Schömig, and I. Ott. 2007. Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27: 769-775.
38. Nystedt, S., V. Ramakrishnan, and J. Sundelin. 1996. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem. 271: 14910-14915.
39. Ritchie, E., M. Saka, C. Mackenzie, R. Drummond, C. Wheeler-Jones, T. Kanke, and R. Plevin. 2007. Cytokine upregulation of proteinase-activated- receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells. Br. J. Pharmacol. 150: 1044-1054.
40. Barber, D. F., M. Faure, and E. O. Long. 2004. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173: 3653-3659.
41. Das, A., and E. O. Long. 2010. Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells. J. Immunol. 185: 4698-4704.
42. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71: 173-183.
43. Umehara, H., E. Bloom, T. Okazaki, N. Domae, and T. Imai. 2001. Fractalkine and vascular injury. Trends Immunol. 22: 602-607.
44. Stegeman, C. A., J. W. Tervaert, M. G. Huitema, P. E. de Jong, and C. G. Kallenberg. 1994. Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup. Arthritis Rheum. 37: 1228-1235.
45. Roussel, L., F. Houle, C. Chan, Y. Yao, J. Bńrubń, R. Olivenstein, J. G. Martin, J. Huot, Q. Hamid, L. Ferri, and S. Rousseau. 2010. IL-17 promotes p38 MAPKdependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J. Immunol. 184: 4531-4537.
46. Hou, L., G. L. Howells, S. Kapas, and M. G. Macey. 1998. The proteaseactivated receptors and their cellular expression and function in blood-related cells. Br. J. Haematol. 101: 1-9.
47. Shpacovitch, V. M., T. Brzoska, J. Buddenkotte, C. Stroh, C. P. Sommerhoff, J. C. Ansel, K. Schulze-Osthoff, N. W. Bunnett, T. A. Luger, and M. Steinhoff. 2002. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J. Invest. Dermatol. 118: 380-385.
48. Ferrell, W. R., J. C. Lockhart, E. B. Kelso, L. Dunning, R. Plevin, S. E. Meek, A. J. Smith, G. D. Hunter, J. S. McLean, F. McGarry, et al. 2003. Essential role for proteinase-activated receptor-2 in arthritis. J. Clin. Invest. 111: 35-41.
49. Csernok, E., M. Ai, W. L. Gross, D. Wicklein, A. Petersen, B. Lindner, P. Lamprecht, J. U. Holle, and B. Hellmich. 2006. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the proteaseactivated receptor-2 pathway. Blood 107: 4440-4448.
50. Csernok, E., J. U. Holle, and W. L. Gross. 2008. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. Clin. Exp. Rheumatol. 26(3, Suppl. 49)S112-S117.